Clinical trials
Phase 2 Mesothelioma, Malignant trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 2 |
| MedImmune LLC | 1 |
| Morphotek | 1 |
| NCIC Clinical Trials Group | 1 |
| National Cancer Institute (NCI) | 1 |
| Ottawa Regional Cancer Centre | 1 |
| Verastem, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 8 |
| Adenocarcinoma, Follicular | 1 |
| Adrenocortical Carcinoma | 1 |
| Astrocytoma | 1 |
| Brain Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Medullary | 1 |
| Central Nervous System Neoplasms | 1 |
| Ependymoma | 1 |
| Glioblastoma | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.